Cavalier Investments, LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 191 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cavalier Investments, LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$1,194,000
-4.5%
76,0000.0%0.40%
-8.6%
Q1 2018$1,250,000
-9.0%
76,0000.0%0.44%
-19.5%
Q4 2017$1,373,000
+184.3%
76,000
+204.0%
0.55%
+136.2%
Q3 2017$483,00025,0000.23%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,340,193$227,22910.94%
Novo Holdings A/S 3,377,768$92,044,1786.80%
Parallel Advisors, LLC 3,723,483$101,446,2943.38%
TANAKA CAPITAL MANAGEMENT INC 37,569$1,0242.92%
S&T BANK/PA 334,252$9,1071.76%
Birchview Capital, LP 50,000$1,362,2501.16%
Granite Investment Partners, LLC 798,552$21,756,5490.91%
FAS Wealth Partners, Inc. 310,764$8,466,7660.90%
Clearview Wealth Advisors LLC 25,258$688,1550.85%
Bridge City Capital, LLC 43,485$1,184,7490.60%
View complete list of CORCEPT THERAPEUTICS INC shareholders